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 2012 Elsevier Ltd. Open access under the ElTerpenes are considered potent skin permeation enhancers with low toxicity. Electron paramagnetic res-
onance (EPR) spectroscopy of the spin label 5-doxyl stearic acid (5-DSA) was used to monitor the effect of
sesquiterpene nerolidol and various monoterpenes on membrane ﬂuidity in erythrocyte and ﬁbroblast
cells. In addition, the hemolytic levels and cytotoxic effects on cultured ﬁbroblast cells were also mea-
sured to investigate possible relationships between the cellular irritation potentials of terpenes and
the ability to modify membrane ﬂuidity. All terpenes increased cell membrane ﬂuidity with no signiﬁcant
differences between the monoterpenes, but the effect of sesquiterpene was signiﬁcantly greater than that
of the monoterpenes. The IC50 values for the terpenes in the cytotoxicity assay indicated that 1,8-cineole
showed lower cytotoxicity and a-terpineol and nerolidol showed higher cytotoxicity. The correlation
between the hemolytic effect and the IC50 values for ﬁbroblast viability was low (R = 0.61); however,
in both tests, nerolidol was among the most aggressive of terpenes and 1,8-cineole was among the least
aggressive. Obtaining information concerning the toxicity and potency of terpenes could aid in the design
of topical formulations optimized to facilitate drug absorption for the treatment of many skin diseases.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Terpenes are volatile constituents of the essential oils of citrus
fruits, cherries, mints and herbs that contain only carbon, hydrogen
and oxygen atoms. They can be chemically classiﬁed as alcohols,
hydrocarbons, ketones and epoxides. Physiologically, terpenes
function primarily as chemoattractants or chemorepellents
(McGarvey and Croteau, 1995) and are largely responsible for the
characteristic fragrance of many plants (Crowell, 1999). Recently,
the potential of terpenes as potent skin permeation enhancers for
drug delivery systems has received considerable attention, espe-
cially because they are naturally occurring substances with low
skin irritation. Many terpenes, including 1,8-cineole, menthol and
a-terpineol, are included on the list of ‘‘Generally Recognized As
Safe’’ (GRAS) materials. Several monoterpenes show no change or
only a slight irritation and cytotoxic effect on cultured human skin
cells (Kitahara et al., 1993). In this context, skin permeation
enhancers, particularly oxygen-containing terpenes, were used as
accelerants of permeation for lipophilic drugs, such as 5-ﬂuoroura-
cil (Cornwell and Barry, 1994), morphine (Morimoto et al., 2002),ance; 5-DSA, 5-doxyl stearic
sevier OA license.imipramine (Jain et al., 2002), hydrocortisone (El-Kattan et al.,
2000) and haloperidol (Vaddi et al., 2002).
A number of dietary monoterpenes have demonstrated anti-
tumor activity and are effective in the chemoprevention and
chemotherapy of cancer (Crowell, 1999; Rabi and Bishayee,
2009; Thoppil and Bishayee, 2011; Gould, 1997; Bardon et al.,
1998, 2002; Wu et al., 2012; Yang and Ping Dou, 2010; Polo
and de Bravo, 2006). The monoterpenes linalool, carvacrol, gera-
niol and terpinen-4-ol have shown activity against Leishmania
infantum promastigotes (Morales et al., 2009). Moreover, terpi-
nen-4-olo and the sesquiterpene nerolidol were reported to
show antifungal (Oliva et al., 2003) and antileishmanial activity
(Arruda et al., 2005), respectively.
Electron paramagnetic resonance (EPR) spectroscopy of spin la-
bels has been recently used to investigate the mechanisms under-
lying the action of terpenes as accelerants of skin permeation. The
intercellular membranes of the stratum corneum, which is the out-
ermost skin layer and primary physical barrier for skin permeation,
become ﬂuid in presence of the terpenes L-menthol (Dos Anjos
et al., 2007) and 1,8-cineole (Anjos et al., 2007). In addition, treat-
ment with monoterpenes increases the partition coefﬁcient of the
small water-soluble spin labels TEMPO (Dos Anjos and Alonso,
2008) and DTBN (Camargos et al., 2010) into stratum corneum
membranes. These results suggest that terpenes might effectively
act as spacers in the membrane to ﬂuidize lipids and create
324 S.A. Mendanha et al. / Toxicology in Vitro 27 (2013) 323–329ruptures in the hydrogen-bond network of the polar interface (Dos
Anjos and Alonso, 2008).
Few studies have investigated whether the ability of terpenes to
facilitate chemical absorption correlates with increased irritation
potentials. Terpenes are important skin permeation enhancers for
drug delivery systems; therefore, we investigated the effect of ner-
olidol, a-terpineol, L()-carvone, (+)-limonene, L-menthone, DL-
menthol, pulegone and 1,8-cineole on erythrocyte membrane ﬂu-
idity. Moreover, the hemolytic potentials and toxicity levels of
these terpenes on ﬁbroblast cells were also investigated.2. Materials and methods
2.1. Chemicals and preparation
Materials for the 3T3 Neutral Red Uptake (NRU) assay and the
spin label 5-doxyl stearic acid (5-DSA) (Fig. 1) were purchased
from Sigma–Aldrich (St. Louis, MO, USA; Steinheim, Germany).
The terpenes were purchased from Acros Organics (Geel, Belgium).
All other chemicals were of the highest grade available and the
buffers were prepared with Milli-Q water.2.2. Cell culture
Balb/c 3T3-A31 ﬁbroblasts were cultured in Dulbecco’s Modi-
ﬁed Eagle’s Medium (DMEM – D5648 Sigma–Aldrich), supple-
mented with 10% fetal bovine serum (FBS-GIBCO) at 37 ± 1 C,
90 ± 10% humidity, 5.0 ± 1.0% CO2/air. The cells were removed from
the culture ﬂasks using trypsinization (trypsin:EDTA solution at a
0.25%:0.02% ratio) when they exceeded 50% conﬂuence but prior
to reaching 80% conﬂuence. Cell viability was evaluated using the
Trypan blue exclusion method with a Neubauer chamber.
A cell suspension containing 3  104 cells/mL was prepared on
the day of plate seeding using culture medium supplemented with
10% FBS. The peripheral wells (blanks) of the 96-well microtiter
plates were seeded with 100 lL of routine culture medium and
the remaining wells received 100 lL of a suspension containing
3  104 cells/mL (3  103 cells/well). The plates were incubated
for 24 ± 2 h (37 ± 1 C; 90 ± 10% humidity, 5.0 ± 1.0% CO2/air) to al-
low the cells to form a monolayer of less than 50% conﬂuence. This
incubation period assured cell recovery, adherence and progres-
sion to the exponential growth phase. Each plate was examined
under a phase contrast microscope to identify experimental and
systemic cell seeding errors.Fig. 1. The chemical structures of two terpenes2.3. The Neutral Red Uptake (NRU) assay
For in vitro assays, the terpenes (nerolidol, a-terpineol, L()-
carvone, (+)-limonene, L-menthone, DL-menthol, pulegone or 1,8-
cineole) were prepared individually as a micellar suspension to al-
low dissolution in water. The micelles were prepared as follows:
10 mg of phosphatidylcholine (PC) and 50 lL of the terpenes to
be tested were dissolved in 50 lL of ethanol. The mixture was son-
icated for 10 min in a Ti-probe sonicator to obtain a homogeneous
dispersion of small micelles. The micellar suspension was prepared
without terpenes for control groups. The experimental samples
were directly diluted in culture medium (DMEM) to obtain the
concentration of use and ﬁltered through a syringe-ﬁlter with a
PES TPP membrane (0.22 lm pore size) to assure sterility. The ﬁ-
nal concentration of ethanol in all cultures was lower than 0.05%.
A Balb/c 3T3-A31 cell suspension containing 3  104 cells/well
was seeded in 96-well plates, and after a 24 h recovery period,
the plates were treated with eight different concentrations of
freshly prepared test compounds in complete medium (six wells
per concentration) and incubated for an additional 48 h. The con-
trol wells (blanks) received complete culture medium supple-
mented with 10% FBS. Subsequently, 250 lL of neutral red (NR)
medium was added to all wells, including the blanks, and incu-
bated (37 ± 1 C, 90 ± 10% humidity, 5.0 ± 1.0% CO2/air) for
3.0 ± 0.1 h. The cells were brieﬂy observed 2–3 h after incubation
for NR crystal formation. After 3 h, the NR medium was removed
and the cells were carefully rinsed with 250 lL/well of pre-
warmed PBS. The PBS was decanted from the plate and 100 lL of
NR desorb (50:1:49 EtOH:acetic acid:water) solution was added
to all wells, including the blanks. The plates were rapidly shaken
on a microplate shaker for 20 min to extract the NR. The absorption
was measured at 545 nm in a microtiter plate reader (spectropho-
tometer). The optical density (OD) was calculated as the difference
between the absorbances at the test wavelength and that at the
reference wavelength. For each concentration tested, the wells
containing no cells served as reference blanks.2.4. Blood processing
The blood samples, obtained from three donors of two blood
banks, were diluted in PBS and centrifuged at 150g for 10 min at
4 C. The plasma and white cells were carefully removed after each
wash (three times).and the spin label 5-DSA used in this work.
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To induce hemolysis, aliquots of terpenes diluted in ethanol
(300 mM) were added to tubes containing erythrocytes suspended
in PBS at a hematocrit concentration of 50% (ﬁnal volume of
100 lL). After gentle shaking, the tubes were incubated at 37 C
for 1.5 h. Subsequently, the erythrocytes were precipitated by cen-
trifugation at 300g and 25 C for 10 min. The magnitude of hemo-
lysis was determined spectrophotometrically at 540 nm according
to the equation:
%hemolysis ¼ Aa  Ac1
Ac2  Ac1
where Ac1 is the control sample (0% terpene), Ac2 is the completely
hemolyzed sample in Milli-Q water and Aa is the sample containing
the desired terpene concentration. Terpene concentration that
causes 50% hemolysis was determined in units of mM. It is well
known that an average human erythrocyte occupies a volume of
approximately 90 fL. The number of cells in the sample and the ratio
of terpenes/cell for 50% hemolysis were calculated based on this
volume.2.6. Erythrocyte and ﬁbroblast membranes labeling and terpene
treatments
The terpenes were dissolved in ethanol to the desired concen-
tration, and 4 lL of the solution was applied directly to the cell sus-
pension (45 lL). The terpene-erythrocyte or terpene-ﬁbroblast
suspensions were incubated at 37 C for 1.5 h. Subsequently, a
small aliquot (1 lL) of the spin label 5-DSA (Fig. 1) dissolved in
ethanol (5 mg/mL) was added to the cells. Each sample consisting
of 5.0  108 RBCs or 1.3  107 ﬁbroblasts in PBS containing 10%
ethanol and the desired terpene concentration was introduced in
capillary tube and ﬂame-sealed for the EPR measurement. Control
samples, with and without ethanol, were measured and it was
found that this concentration of ethanol did not signiﬁcantly alter
the membrane ﬂuidity in either RBC or ﬁbroblast cells. In calculat-
ing the ratio of terpene molecules/cell for each sample, the eryth-
rocyte volume was considered to be 90 fL and for ﬁbroblast

















Fig. 2. Balb/c 3T3-A31 NRU cytotoxicity assay after exposing the cells to two
representative terpenes for 48 h. Nerolidol and 1,8-cineole were, respectively, the
most and the least cytotoxic among the eight tested terpenes. The data represent
the mean cell viability ± SD (%) from three independent experiments.2.7. EPR spectroscopy
The EPR spectra were recorded using a Bruker ESP 300 spec-
trometer (Rheinstetten, Germany) equipped with an ER 4102 ST
resonator. The instrument was programmed with the following
settings: microwave power, 2 mW; modulation frequency,
100 kHz; modulation amplitude, 1.0 G; magnetic ﬁeld scan,
100 G; sweep time, 168 s; and detector time constant, 41 ms. All
measurements were performed at room temperature (24–26 C).
The EPR spectra simulations were performed using nonlinear
least-square (NLLS) ﬁts and the general slow-motion program
(Schneider and Freed, 1989; Budil et al., 1996). The rotational dif-
fusion rate, Rbar, obtained from NLLS was converted to the rota-
tional correlation time, sc, through the relationship sc = 1/6 Rbar
(Schneider and Freed, 1989). Similar to previous studies (Alonso
et al., 2001, 2003; Queirós et al., 2005), the magnetic parameters
were determined based on the global analysis of the overall spectra
obtained in this work, and all of the EPR spectra were simulated
using the same predetermined parameters. The magnetic g and A
tensors are deﬁned in a molecule-ﬁxed frame, where the constants
of rotational diffusion rates around the x, y and z axes are included.
The input parameters of tensors g and A were: gxx = 2.0088;
gyy = 2.0060; gzz = 2.0026; Axx = 6.1; Ayy = 6.3 G; Azz = 36.5 G.2.8. Statistical analysis
Data from the microtiter plate reader were transferred to a
spreadsheet template GraphPad Prism to determine the cell via-
bility, calculate the IC50 values using linear interpolation, and per-
form the statistical analyses.
Concentration–response curves were constructed and ﬁtted in
Origin 8.0 using parametric nonlinear regression. IC50 values were
computed using the ﬁtted Hill equation and presented as the
mean ± standard deviation (SD) of at least three independent
experiments with 4 repetitions in each experiment (12 experimen-
tal values for each compound). IC50 data were compared by one-
way analysis of variance (ANOVA) followed by Tukey’s multiple
range test for statistically signiﬁcant differences at P < 0.05.
3. Results
3.1. Cytotoxicity of the terpenes
In the present study we used the 3T3 NRU to evaluate the cyto-
toxicity of eight terpenes. The results were obtained for different
concentrations of terpenes in a Balb/c 3T3-A31 NRU cytotoxicity
assay after incubation for 48 h. Fig. 2 shows the concentration
dependence of cell viability for the terpenes of higher and lower
cytotoxicity. The IC50 values for the eight tested terpenes are pre-
sented in Table 1.
3.2. Hemolytic effects of the terpenes
The hemolytic effects of the terpenes on human erythrocytes
were evaluated after 1.5 h incubation. Ethanol was used as a vehi-
cle to optimize the incorporation of terpenes into the RBC mem-
branes; the hemolytic effect of ethanol was previously
characterized. The levels of ethanol-induced hemolysis measured
at 50% hematocrit (Fig. 3A) indicate that damage occurs only at
an ethanol concentration above 10% (v/v).
The hemolytic potential can be used to indicate the toxicity of
molecules on human erythrocytes (Benavides et al., 2004). In
Fig. 3B was plotted the concentration dependence of the most
hemolytic terpene (nerolidol) and a less hemolytic terpene
(1,8-cineole). Nerolidol is hemolytic at very low concentrations,
whereas 1,8-cineole shows signiﬁcant levels of hemolysis only
for concentrations above 10 mM. For the other terpenes used in
Table 1
IC50 values of terpenes obtained from Balb/c 3T3 – A31 NRU cytotoxicity assay after
48 h exposure.
Terpene IC50 (mM)*
Nerolidol 0.06 ± 0.01a,**
a-Terpineol 0.13 ± 0.01a
L()-carvone 0.93 ± 0.18b
Pulegone 1.01 ± 0.21b
DL-menthol 1.58 ± 0.26c
L-menthone 1.74 ± 0.13c
(+)-Limonene 1.58 ± 0.05c
1,8-Cineole 4.02 ± 0.15d
The means and SD were calculated from three independent experiments.
* In this experiment 1 mM corresponds to 1013 terpenes/cell.
** Statistical signiﬁcance: means that are not marked with the same letter are
statistically different at P < 0.05 (Tukey test).




































Fig. 3. (A) The hemolysis levels induced after incubating 50% hematocrit erythro-
cyte suspensions with different ethanol concentrations for 1.5 h. (B) The hemolysis
levels induced after incubating 50% hematocrit erythrocyte suspension with
different concentrations of nerolidol and 1,8-cineole for 1.5 h.
Table 2
Terpene concentration for 50% hemolysis, after 90 min incubation in RBC suspension.
Terpene Concentration (mM) (108 terpenes/RBC)
(+)-Limonene 23.8 ± 0.5a,* 26.0 ± 0.6
1,8-Cineole 18.4 ± 0.6b 20.1 ± 0.7
L()-carvone 10.5 ± 1.4c 11.4 ± 1.6
Pulegone 9.6 ± 0.5c 10.5 ± 0.6
L-menthone 8.3 ± 0.9c,d 9.0 ± 1.0
a-Terpineol 6.1 ± 0.6d,e 6.6 ± 0.7
DL-menthol 4.9 ± 1.1e 5.3 ± 1.2
Nerolidol 2.3 ± 0.8f 2.5 ± 0.9
The means and SD were calculated from three independent experiments.
* Statistical signiﬁcance: means that are not marked with the same letter are sta-
tistically different at P < 0.05 (Tukey test).




















Fig. 4. Correlation between the terpene concentrations required for 50% hemolysis
and those needed to obtain the IC50 cell viability. Each point in the graph
corresponds to one terpene (Tables 1 and 2). Symbols: 1,8-cineole, solid squares; a-
terpineol, open stars; DL-menthol, solid triangles; L()-carvone, solid stars; (+)-
limonene, solid circles; pulegone, open diamonds; L-menthone, open squares;
nerolidol, open circles. The value obtained for the correlation coefﬁcient (R) was
0.61.
326 S.A. Mendanha et al. / Toxicology in Vitro 27 (2013) 323–329this work, hemolysis occurs at concentrations between 1.0 and
6.0 mM. The terpene concentration that causes 50% hemolysis
was determined based on the sigmoid curve ﬁtting for each mole-
cule, and the values obtained are presented in Table 2.
To examine the potential correlation between the hemolytic ef-
fect and the cell viability of ﬁbroblasts exposed to terpenes, the
concentration that causes 50% hemolysis for each terpene was
plotted against that for IC50 (Fig. 4); a weak correlation (R = 0.61)
was observed.3.3. Alteration in membrane ﬂuidity
The experimental (black line) and best-ﬁt (red line) EPR spectra
5-DSA in erythrocyte membranes untreated and treated with the
terpenes 1,8-cineole and nerolidol are shown in Fig. 5. Spectral
simulations allowed us to evaluate the mobility of the spin label
in erythrocyte membrane. The experimental line shapes were ﬁt-
ted with the program NLLS using models of one or two spectral
components. The presence of two components in the spectra was
only observed at high concentrations of some terpenes. The aver-
age of sc was calculated according to the equation: sc = N1  sc1 + -
N2  sc2, where N1 and N2 are the population of component 1 and 2,
respectively, and sc1 and sc2 are the respective rotation correlation
times. The behavior of the sc parameter with the terpene concen-
tration in RBC suspension is shown in Fig. 6. Upon nerolidol addi-
tion, the sc increases signiﬁcantly until the terpene:cell ratio
reaches 19  109:1. Notably, while the effects of the monoter-
penes were similar along the entire concentration range, the ses-
quiterpene (nerolidol) showed a considerably greater effect,
similar to the hemolytic effect and cell viability.
To compare the terpene concentration that causes cytotoxic ef-
fects on ﬁbroblasts with terpene concentration that changes mem-
brane ﬂuidity, we performed a measure of ﬂuidity directly on the
ﬁbroblast membrane. Fig. 7 shows the EPR spectra and the corre-






Fig. 5. Experimental (black line) and best-ﬁt (red line) EPR spectra of the 5-DSA in
the erythrocyte membranes in the absence of terpenes and after incubating for
90 min with 1,8-cineole or nerolidol at a terpene:cell ratio of 12.7  1010:1 The
best-ﬁt spectra were obtained using a NLLS ﬁt with models for one or two spectral
components. The values of the EPR parameter rotational correlation time (sc)
obtained from the ﬁts are indicated. The total scan range of the magnetic ﬁeld was
100 G. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the web version of this article.)













Fig. 6. The rotational correlation time, sc, for the 5-DSA within the erythrocyte
membranes versus the number of terpenes/erythrocyte. Symbols: 1,8-cineole, solid
squares; a-terpineol, open stars; DL-menthol, solid triangles; L()-carvone, solid
stars; (+)-limonene, solid circles; pulegone, open diamonds; L-menthone, open


















Fig. 7. Experimental (line) and best-ﬁt (circles) EPR spectra of the 5-DSA in the
ﬁbroblast membranes for an untreated sample (control) and for ﬁbroblasts treated
with several terpenes (90 min incubation) at a terpene:cell ratio of 6.3  1010:1. The
best-ﬁt spectra were obtained using a NLLS ﬁt with a model of two spectral
components. The values of the EPR parameter rotational correlation time (sc)
obtained from the ﬁts are indicated. The experimental error is estimated to be
0.2 ns.
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ﬂuidity, and nerolidol was the most potent. Comparing the sc val-
ues for the control samples in Figs. 5 and 7, it can be noted that the
ﬁbroblast membrane is much more ﬂuid than that of erythrocytes.4. Discussion
Chemical penetration enhancers are important for use in trans-
dermal drug delivery systems and as components of formulations
to enhance topical drug absorption for the treatment of many skin
diseases. However, the difﬁculty of restricting their effects to the
outermost stratum corneum layer to avoid irritation or toxicity
in deeper skin layers has severely limited their application (Praus-nitz and Langer, 2008). It is generally accepted that chemical
enhancers might increase the permeability of a drug by affecting
the intercellular lipids of the stratum corneum via lipid extraction
or ﬂuidization (Barry, 1991; Yamane et al., 1995; Zhao and Singh,
1998). In a study to design skin permeation enhancers in order
to optimize the balance between penetration enhancement and
low irritation potential, the researchers observed that the use of
chemical enhancers as lipid extractors demonstrated a direct cor-
relation between permeability and skin irritation, which was not
previously observed for typical ﬂuidizers (Karande et al., 2005).
In the present study, we showed that monoterpenes increase the
lipid dynamics in the human erythrocyte membrane, but their
individual effects are not signiﬁcantly different. This result is con-
sistent with recently reported data (Dos Anjos et al., 2007; Anjos
et al., 2007; Dos Anjos and Alonso, 2008, Camargos et al., 2010),
that indicated strong increases of membrane ﬂuidity in stratum
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penes, but no signiﬁcant differences were observed between them.
Thus, combinations of monoterpenes that facilitate the partition of
small drugs with low potential of skin irritation, such as limonene
and cineole, with the sesquiterpene nerolidol, which is cytotoxic
but has the ability to destabilize the membrane, could be used to
achieve the effective permeation of polar and nonpolar drugs
through the skin.
As Jain and coworkers (Jain et al., 2002) proposed, terpenes,
such as a-terpineol and DL-menthol, which have alcoholic OH
groups that act as H-bond donors, could disrupt the existing net-
work of hydrogen bonds within stratum corneum membranes to
facilitate the permeation of drugs through the skin. Whereas terp-
enes, such as menthone, pulegone, carvone and cineole, that only
possess hydrogen bond acceptors (carbonyl or ether groups) pres-
ent a less extensive disruption of the H-bond network and, there-
fore, show a reduced ability to enhance drug permeation.
Similarly, our data showed that the monoterpenes a-terpineol
and DL-menthol (H-bond donors) are highly hemolytic; menthone,
pulegone, carvone and cineole (acceptors of H-bonds) have moder-
ate hemolytic potential, and limonene, which does not form
H-bonds, presented the lowest hemolytic potential. However, the
sesquiterpene nerolidol that contained an OH group showed the
highest hemolytic and cytotoxic effects. Generally, terpenes might
compete with water-mediated intermolecular hydrogen bonding
between the lipid molecules, disrupting the hydrogen bond net-
work of the lipid bilayer and weakening the membrane. An impor-
tant result of this work is that the monoterpenes did not differ
signiﬁcantly in their potency to increase membrane ﬂuidity, but
they did differ in their ability to disrupt the erythrocyte membrane
(Table 2) and to cause cytotoxicity in ﬁbroblasts (Table 1). The less
polar monoterpenes, limonene and cineole, showed less aggression
to the membrane and low cytotoxicity. Nerolidol showed greater
potency to increase membrane ﬂuidity but also increased ability
to disrupt the membrane and increased cytotoxic potential.
The nerolidol concentration that caused 50% hemolysis was
approximately 2.5  108 molecules/cell (Table 2), whereas the con-
centration that produced a signiﬁcant increase in erythrocyte
membrane ﬂuidity was 2.5  109 molecules/cell. Thus, the change
in membrane ﬂuidity was observed at a concentration 10 times
greater than that for hemolysis. This result could be explained by
the fact that the spin probes are sparsely distributed in the mem-
brane and, therefore, the spin probe spectroscopy only detects
changes in ﬂuidity when a widespread change occurs in the mem-
brane. The molar ratio between spin probe and lipid present in the
membranes used for the EPR measurements was 1:200. Thus, to
detect changes in membrane ﬂuidity, the environment of most
spin labels would have to be changed. This result also suggests that
a highly localized change in the erythrocyte membrane is sufﬁcient
to provoke hemolysis. In cell cytotoxicity, the IC50 of nerolidol was
6  1011 molecules/ﬁbroblast and the concentration that alters
ﬁbroblast membrane ﬂuidity was approximately 10 times lower
(6.3  1010 terpenes/cell). These calculations indicate that the con-
centrations that cause a general change in ﬁbroblast membrane
ﬂuidity are smaller than those that inhibit the growth of ﬁbro-
blasts. This result is indicative of the low toxicity of terpenes in cul-
tured ﬁbroblasts and suggests that, unlike in red blood cells,
change in ﬁbroblast membrane ﬂuidity occurs without disruption
of the membrane.
In conclusion, we examined the hemolytic potential and cyto-
toxicity in ﬁbroblasts treated with terpenes and showed that these
reagents cause cellular injury in a concentration-dependent man-
ner. Nerolidol, a-terpineol and DL-menthol were the most hemo-
lytic and limonene and 1,8-cineole were the least hemolytic,
whereas in the cytotoxicity assay, nerolidol and a-terpineol were
the most cytotoxic and 1,8-cineole was the least cytotoxic; how-ever, the correlation coefﬁcient between the two tests was low
(R = 0.61). This study demonstrated that monoterpenes are power-
ful membrane ﬂuidizers in erythrocyte and ﬁbroblast cells, and the
observed effects were not signiﬁcantly different among them, sug-
gesting that they possess the same potency in enhancing dermal
permeation. However, less polar monoterpenes, such as limonene
and cineole, showed low membrane aggressiveness and cytotoxic-
ity. The sesquiterpene produced the greatest increase in membrane
ﬂuidity, but also a greater irritation potential. Although the mech-
anisms of cytotoxicity were not investigated, we suggest that terp-
enes could trigger various mechanisms, including interactions with
the cellular membrane, which most likely occur during terpene-in-
duced hemolysis. The antiproliferative effects of monoterpenes
have been previously demonstrated through the modulation of
gene expression associated with apoptosis (Bardon et al., 1998,
2002; Yang and Ping Dou, 2010; Wu et al., 2012). Given that some
monoterpenes show activity against Leishmania infantum prom-
astigotes (Morales et al., 2009) and the sesquiterpene nerolidol
inhibits the growth of several species of Leishmania promastigotes
and amostigotas (Arruda et al., 2005), these reagents are interest-
ing candidates as components of formulations for the topical treat-
ment of cutaneous Leishmania. In this case, the terpenes or their
combinations would not only serve as chemical permeation
enhancers of drugs with antileishmanial activity but could also
contribute to the antiparasitic treatment.Acknowledgments
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